StonvexLoading…
StonvexCore line items from CCI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $215.00M | $192.00M | $421.00M | $697.00M |
Operating Income | $2.08B | $2.12B | $2.10B | $2.42B |
Net Income | $444.00M | $-3.90B | $1.50B | $1.68B |
EPS (Diluted) | $1.01 | $-8.98 | $3.46 | $3.86 |
Total Assets | $31.52B | $32.74B | $38.53B | $38.92B |
Total Liabilities | $33.15B | $32.87B | $32.15B | $31.47B |
Cash & Equivalents | $99.00M | $100.00M | $105.00M | $156.00M |
Free Cash Flow OCF − CapEx | $2.88B | $2.77B | $2.88B | $1.57B |
Shares Outstanding | 435.00M | 435.00M | 434.00M | 433.00M |